Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S SCHWARTZBERG

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
Cancer Treatment and Research Communications|February 21, 2019
Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settingsArthur C Houts, Tope Olufade, Rahul Shenolikar, et al.
BMC Nursing|July 12, 2005
Experiencing neutropenia: quality of life interviews with adult cancer patientsBarry V Fortner, Kurt W Tauer, Ted Okon, et al.
Journal of Comparative Effectiveness Research|May 10, 2019
Real-world effectiveness of palonosetron-based antiemetic regimens: preventing chemotherapy-induced nausea and vomitingLee S Schwartzberg, Stanley M Marks, Nashat Y Gabrail, et al.
Clinical Lung Cancer|November 7, 2017
Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology SettingsMark S Walker, William Wong, Arliene Ravelo, et al.
The Journal of Supportive Oncology|December 17, 2005
Baseline evaluation of assessment, information, and management patterns in a national quality improvement projectGina Johnson, Barry Fortner, Kelley Moore, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2009
Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancerLee S Schwartzberg, Patrick Cobb, Mark S Walker, et al.
Health and Quality of Life Outcomes|August 16, 2017
Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry studyMark S Walker, William Wong, Arliene Ravelo, et al.
Journal of Comparative Effectiveness Research|October 12, 2018
Real-world efficacy: intravenous palonosetron three-drug regimen for chemotherapy-induced nausea and vomiting with highly emetogenic chemotherapyLee S Schwartzberg, Trent McLaughlin, Robert B Geller, et al.
Gynecologic Oncology|September 11, 2012
Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinomaTodd D Tillmanns, M Patrick Lowe, Mark S Walker, et al.
Clinical Breast Cancer|December 14, 2011
Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancerLee S Schwartzberg, Francis P Arena, David M Mintzer, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
Cancer Treatment and Research Communications|February 21, 2019
Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settingsArthur C Houts, Tope Olufade, Rahul Shenolikar, et al.
BMC Nursing|July 12, 2005
Experiencing neutropenia: quality of life interviews with adult cancer patientsBarry V Fortner, Kurt W Tauer, Ted Okon, et al.
Journal of Comparative Effectiveness Research|May 10, 2019
Real-world effectiveness of palonosetron-based antiemetic regimens: preventing chemotherapy-induced nausea and vomitingLee S Schwartzberg, Stanley M Marks, Nashat Y Gabrail, et al.
Clinical Lung Cancer|November 7, 2017
Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology SettingsMark S Walker, William Wong, Arliene Ravelo, et al.
The Journal of Supportive Oncology|December 17, 2005
Baseline evaluation of assessment, information, and management patterns in a national quality improvement projectGina Johnson, Barry Fortner, Kelley Moore, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2009
Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancerLee S Schwartzberg, Patrick Cobb, Mark S Walker, et al.
Health and Quality of Life Outcomes|August 16, 2017
Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry studyMark S Walker, William Wong, Arliene Ravelo, et al.
Journal of Comparative Effectiveness Research|October 12, 2018
Real-world efficacy: intravenous palonosetron three-drug regimen for chemotherapy-induced nausea and vomiting with highly emetogenic chemotherapyLee S Schwartzberg, Trent McLaughlin, Robert B Geller, et al.
Gynecologic Oncology|September 11, 2012
Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinomaTodd D Tillmanns, M Patrick Lowe, Mark S Walker, et al.
Clinical Breast Cancer|December 14, 2011
Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancerLee S Schwartzberg, Francis P Arena, David M Mintzer, et al.
Pageof 23